Genome-Wide association study of a heart failure related metabolomic profile among african americans in the atherosclerosis risk in communities (ARIC) study

Genetic Epidemiology

Volumn 37, Issue 8, 2013, Pages 840-845

  Yu, Bing ^a   Zheng, Yan ^a   Alexander, Danny ^b   Manolio, Teri A ^c   Alonso, Alvaro ^d   Nettleton, Jennifer A ^a   Boerwinkle, Eric ^a,e  

^a UNIVERSITY OF TEXAS   (United States)

^b METABOLON INC   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

African Americans; Genome wide association; Heart failure; Metabolomics

Indexed keywords

ACYLTRANSFERASE; LEUCINE;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHROMOSOME; CHROMOSOME 2P; CHROMOSOME 5Q; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; METABOLOMICS; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; GENOME-WIDE ASSOCIATION; HEART FAILURE; METABOLOMICS;

ACETYLTRANSFERASES; AFRICAN AMERICANS; ALLELES; ATHEROSCLEROSIS; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 5; COHORT STUDIES; FATTY ACIDS, UNSATURATED; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEART FAILURE; HUMANS; INCIDENCE; ISOLEUCINE; LEUCINE; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRROLIDONECARBOXYLIC ACID; RISK FACTORS;

EID: 84887612884     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21752     Document Type: Article

References (37)

1. Anderson JL, Horne BD, Camp NJ, Muhlestein JB, Hopkins PN, Cannon-Albright LA, Mower CP, Park JJ, Clarke JL, Nicholas ZP, and others. 2010 Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease. Am Heart J 160(2):250-256.
2. Aulchenko YS, Struchalin MV, van Duijn CM. 2010. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 11:134.
3. Berlett BS, Stadtman ER. 1997. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272(33):20313-20316.
4. Bode BP. 2001. Recent molecular advances in mammalian glutamine transport. J Nutr 131(9 Suppl):2475S-2485S.
5. Boll M, Foltz M, Rubio-Aliaga I, Kottra G, Daniel H. 2002. Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters. J. Biol. Chem. 277(25):22966-22973.
6. Broer S, Bailey CG, Kowalczuk S, Ng C, Vanslambrouck JM, Rodgers H, Auray-Blais C, Cavanaugh JA, Broer A, Rasko JE. 2008. Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. J Clin Invest 118(12):3881-3892.
7. Chambers JC, Zhang W, Lord GM, van der Harst P, Lawlor DA, Sehmi JS, Gale DP, Wass MN, Ahmadi KR, Bakker SJ, and others. 2010. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42(5):373-375.
8. de Champlain J, Wu R, Girouard H, Karas M, Laplante MA, Wu L. 2004. Oxidative stress in hypertension. Clin Exp Hypertens 26(7-8):593-601.
9. Dunn WB, Broadhurst DI, Deepak SM, Buch MH, McDowell G, Spasic I, Ellis DI, Brooks N, Kell DB, Neyses L. 2007. Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate. Metabolomics 3(4):413-426.
10. Fu SL, Dean RT. 1997. Structural characterization of the products of hydroxyl-radical damage to leucine and their detection on proteins. Biochem J 324(Pt 1):41-48.
11. Grambsch PM, Therneau TM. 1994. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515-526.
12. Griffin JL, Atherton H, Shockcor J, Atzori L. 2011. Metabolomics as a tool for cardiac research. Nat Rev Cardiol 8(11):630-643.
13. Haldeman GA, Croft JB, Giles WH, Rashidee A. 1999. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137(2):352-360.
14. Hirschhorn JN, Daly MJ. 2005. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6(2):95-108.
15. Joy T, Cao H, Black G, Malik R, Charlton-Menys V, Hegele RA, Durrington PN. 2007. Alstrom syndrome (OMIM 203800): a case report and literature review. Orphanet J Rare Dis 2:49.
16. Kannel WB. 2000. Incidence and epidemiology of heart failure. Heart Fail Rev 5(2):167-173.
17. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, and others. 2010. New loci associated with kidney function and chronic kidney disease. Nat Genet 42(5):376-384.
18. Larson MG, Atwood LD, Benjamin EJ, Cupples LA, D'Agostino RB, Sr., Fox CS, Govindaraju DR, Guo CY, Heard-Costa NL, Hwang SJ, and others. 2007. Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet 8(Suppl 1):S5.
19. Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE. 2008. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 101(7):1016-1022.
20. Maritim AC, Sanders RA, Watkins JB. 2003. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17(1):24-38.
21. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy M, Kane JP, Pankow JS, Devlin JJ, Willerson JT, Boerwinkle E. 2007. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 166(1):28-35.
22. Nicholson JK, Lindon JC, Holmes E. 1999. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11):1181-1189.
23. Ozaki K, Fujiwara T, Nakamura Y, Takahashi E. 1998. Isolation and mapping of a novel human kidney- and liver-specific gene homologous to the bacterial acetyltransferases. J Hum Genet 43(4):255-258.
24. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8):904-909.
25. Rich MW. 1997. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 45(8):968-974.
26. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, and others. 2011. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123(4):e18-e209.
27. Singh U, Jialal I. 2006. Oxidative stress and atherosclerosis. Pathophysiology 13(3):129-142.
28. Small DM, Coombes JS, Bennett N, Johnson DW, Gobe GC. 2012. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) 17(4): 311-321.
29. Smith NL, Felix JF, Morrison AC, Demissie S, Glazer NL, Loehr LR, Cupples LA, Dehghan A, Lumley T, Rosamond WD, and others. 2010. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet 3(3):256-266.
30. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B, Altmaier E, Deloukas P, Erdmann J, Grundberg E, and others. 2011. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477(7362): 54-60.
31. The ARIC investigators. 1989. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129(4): 687-702.
32. Tuunanen H, Ukkonen H, Knuuti J. 2008. Myocardial fatty acid metabolism and cardiac performance in heart failure. Curr Cardiol Rep 10(2):142-148.
33. van der Greef J, Stroobant P, van der Heijden R. 2004. The role of analytical sciences in medical systems biology. Curr Opin Chem Biol 8(5):559-565.
34. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, and others. 2011. Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448-453.
35. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, and others. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57-63.
36. White AD, Folsom AR, Chambless LE, Sharret AR, Yang K, Conwill D, Higgins M, Williams OD, Tyroler HA. 1996. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 49(2):223-233.
37. Zheng Y, Yu B, Alexander D, Manolio TA, Aguilar D, Coresh J, Heiss G, Boerwinkle E, Nettleton JA. 2013. Associations between Metabolomic Compounds and Incident Heart Failure among African Americans: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol [Epub ahead of print].